Yoichi Yasuda

886 total citations
18 papers, 748 citations indexed

About

Yoichi Yasuda is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Yoichi Yasuda has authored 18 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 6 papers in Cancer Research. Recurrent topics in Yoichi Yasuda's work include Retinoids in leukemia and cellular processes (5 papers), Tea Polyphenols and Effects (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Yoichi Yasuda is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Tea Polyphenols and Effects (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Yoichi Yasuda collaborates with scholars based in Japan, Thailand and United States. Yoichi Yasuda's co-authors include Hisataka Moriwaki, Masahito Shimizu, Hiroyasu Sakai, Hisashi Tsurumi, Yohei Shirakami, Masaya Kubota, Takuji Tanaka, Yukihiko Hara, Seiji Adachi and Tomohiko Ohno and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Clinical Cancer Research.

In The Last Decade

Yoichi Yasuda

18 papers receiving 728 citations

Peers

Yoichi Yasuda

PFM

EPIDE

BIOCH

Bong Whan Ahn South Korea

Tomohiko Ohno Japan

Yuan‐Chiang Chung Taiwan

Te-Mao Li Taiwan

Marina Orlandi Italy

Pengqi Wang China

Saori Abe Japan

Jong Won Choi South Korea

Sin Young Choi South Korea

Bo‐Wen Lin Taiwan

Bong Whan Ahn South Korea

Yoichi Yasuda

379 ×1.2

173 ×0.8

PFM

55 ×0.3

EPIDE

153 ×0.9

107 ×0.8

BIOCH

Citations per year, relative to Yoichi Yasuda Yoichi Yasuda (= 1×) peers Bong Whan Ahn

Countries citing papers authored by Yoichi Yasuda

Since Specialization

Citations

This map shows the geographic impact of Yoichi Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichi Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichi Yasuda more than expected).

Fields of papers citing papers by Yoichi Yasuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichi Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichi Yasuda. The network helps show where Yoichi Yasuda may publish in the future.

Co-authorship network of co-authors of Yoichi Yasuda

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichi Yasuda. A scholar is included among the top collaborators of Yoichi Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichi Yasuda. Yoichi Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Yasuda, Yoichi, et al.. (2014). A Study on the Prevention of Wheel-Climb Derailment at Low Speed Ranges. 30. 5 indexed citations

Mochizuki, Kiyofumi, et al.. (2012). Discrepancy of in-vitro data and clinical efficacy of micafungin against Candida tropicalis endophthalmitis. Journal of Infection and Chemotherapy. 18(5). 786–789. 7 indexed citations

Nakagawa, Takayuki, Yoichi Yasuda, Kensaku Yoshida, et al.. (2012). A case of malignant melanoma simultaneously found in the lung and small intestine. Clinical Journal of Gastroenterology. 6(1). 25–28. 2 indexed citations

Ohno, Tomohiko, Yohei Shirakami, Masahito Shimizu, et al.. (2012). Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand. Cancer Letters. 323(2). 215–222. 29 indexed citations

Shimizu, Masahito, Yoichi Yasuda, Hiroyasu Sakai, et al.. (2011). Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/dbobese mice. BMC Cancer. 11(1). 281–281. 43 indexed citations

Kubota, Masaya, Masahito Shimizu, Hiroyasu Sakai, et al.. (2011). Renin–angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Biochemical and Biophysical Research Communications. 410(1). 108–113. 42 indexed citations

Osawa, Yosuke, Hiromitsu Kanamori, Ekihiro Seki, et al.. (2011). l-Tryptophan-mediated Enhancement of Susceptibility to Nonalcoholic Fatty Liver Disease Is Dependent on the Mammalian Target of Rapamycin. Journal of Biological Chemistry. 286(40). 34800–34808. 71 indexed citations

Kubota, Masaya, Masahito Shimizu, Hiroyasu Sakai, et al.. (2011). Preventive Effects of Curcumin on the Development of Azoxymethane-Induced Colonic Preneoplastic Lesions in Male C57BL/KsJ-db/dbObese Mice. Nutrition and Cancer. 64(1). 72–79. 49 indexed citations

Shimizu, Masahito, Hiroyasu Sakai, Yohei Shirakami, et al.. (2011). Preventive Effects of (−)-Epigallocatechin Gallate on Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-db/db Mice. Cancer Prevention Research. 4(3). 396–403. 64 indexed citations

10.

Shimizu, Masahito, Hiroyasu Sakai, Yohei Shirakami, et al.. (2011). Abstract 844: Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Research. 71(8_Supplement). 844–844. 2 indexed citations

11.

Shimizu, Masahito, Hiroyasu Sakai, Yohei Shirakami, et al.. (2010). Acyclic Retinoid Inhibits Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BLKS/J- +Lepr db /+Lepr db Mice. Cancer Prevention Research. 4(1). 128–136. 49 indexed citations

12.

Yasuda, Yoichi, Masahito Shimizu, Yohei Shirakami, et al.. (2010). Pitavastatin inhibits azoxymethane‐induced colonic preneoplastic lesions in C57BL/KsJ‐db/db obese mice. Cancer Science. 101(7). 1701–1707. 55 indexed citations

13.

Shimizu, Masahito, Yohei Shirakami, Hiroyasu Sakai, et al.. (2010). (−)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chemico-Biological Interactions. 185(3). 247–252. 94 indexed citations

14.

Yasuda, Yoichi, et al.. (2010). Effect ofDuabanga grandiflorafor Human Skin Cells. The American Journal of Chinese Medicine. 38(2). 387–399. 6 indexed citations

15.

Yasuda, Yoichi, Masahito Shimizu, Hiroyasu Sakai, et al.. (2009). (−)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRβ and IGF-1R. Chemico-Biological Interactions. 182(2-3). 159–164. 51 indexed citations

16.

Shirakami, Yohei, Masahito Shimizu, Seiji Adachi, et al.. (2009). (–)‐Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor–vascular endothelial growth factor receptor axis. Cancer Science. 100(10). 1957–1962. 87 indexed citations

17.

Shimizu, Masahito, Yohei Shirakami, Hiroyasu Sakai, et al.. (2009). Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells. Cancer Letters. 285(2). 210–217. 31 indexed citations

18.

Shimizu, Masahito, Yohei Shirakami, Junpei Iwasa, et al.. (2009). Supplementation with Branched-chain Amino Acids Inhibits Azoxymethane-induced Colonic Preneoplastic Lesions in Male C57BL/KsJ-db/db Mice. Clinical Cancer Research. 15(9). 3068–3075. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact